Home LiteratureArticle Details

PMID: 29624699 Published · ppublish English Journal Article Practice Guideline Research Support, Non-U.S. Gov't

Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases.

Hepatology (Baltimore, Md.) ·Vol. 68 ·No. 2 ·2018-00-00 ·Pages 723-750

Marrero JA, Kulik LM, Sirlin CB, Zhu AX, Finn RS, Abecassis MM, Roberts LR, Heimbach JK

Abstract

暂无摘要

MeSH Terms

Antineoplastic Agents/therapeutic use Carcinoma, Hepatocellular/diagnosis,therapy Early Detection of Cancer/methods Female Hepatectomy/methods Humans Liver/pathology Liver Neoplasms/diagnosis,therapy Liver Transplantation/methods Male Neoplasm Staging United States

Chemicals

Antineoplastic Agents

Authors & Affiliations

8 authors, click to expand affiliations / ORCID

Marrero Jorge A

UT Southwestern Medical Center, Dallas, TX.

Kulik Laura M

Northwestern Medicine, Chicago, IL.

Sirlin Claude B

University of California SanDiego, San Diego, CA.

Zhu Andrew X

Massachusets General Hospital, Boston, MA.

Finn Richard S

UCLA Medical Center, Los Angeles, CA.

Abecassis Michael M

Northwestern Medicine, Chicago, IL.

Roberts Lewis R ORCID

Mayo Clinic, Rochester, MN.

Heimbach Julie K

Mayo Clinic, Rochester, MN.

Article Info

Journal

Hepatology (Baltimore, Md.)

Abbr.

Hepatology

ISSN

1527-3350

DOI

10.1002/hep.29913

Published

2018-00-00

Pages

723-750

Language

English

Region

United States

NLM ID

8302946

Subset

Corrections

CommentIn

PMID: 30070377

External Links

PubMed source DOI: 10.1002/hep.29913 View journal details

Analysis Services

Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases.

Contact

WeChat Official Account